coadministered cagrilintide and semaglutide in adults with overweight or obesity the REDEFINE 2 phase 3a trial involving diabetes, the use of cagrilintide–semaglutide resulted in a significantly lower body weight than placebo at 68 weeks. Full trial results Cagrilintide–semaglutide (CagriSema) versus semaglutide or

Choosing the right foodsbland, protein-forward, and smaller portionscan ease symptoms while your body adapts to GLP-1 therapy

Retatrutide is emerging as one of the most promising metabolic therapies in development today

Gluten-free, dairy-free, soy-free

Acarbose, an AGI, has been shown in pre-clinical models to increase lifespan (greater longevity benefits in males), with decreased body weight gain independent of calorie intake reduction

Achieve sustainable weight loss with semaglutide in Georgetown, TX

In the eyes of some patients who feel especially empowered and health-bent, the medical home might be the family home